Fas / FasL system, IL‐1β expression and apoptosis in chronic HBV and HCV liver disease
- 4 June 2008
- journal article
- Published by Wiley in Journal of Viral Hepatitis
- Vol. 15 (7) , 515-522
Abstract
Summary. The Fas / Fas‐ligand (FasL) system is an important death signal pathway in the liver. An enhanced local inflammatory response prompted by FasL expression, which contributes to neutrophil recruitment and interleukin‐1 beta (IL‐1β) release, seems to be crucial to chronic liver damage, persistence of viral infections, and probably initiation and / or promotion of HCC. In order to evaluate the expression of Fas, FasL, and IL‐1β in different stages of human liver disease and to determine whether hepatitis B virus (HBV) and hepatitis C virus (HCV) infections modulate their expression, also in relation to apoptosis, we examined 87 liver samples obtained from patients with: chronic hepatitis (CH) (n.42), cirrhosis (n.9) and hepatocellular carcinoma (HCC) (n.16) and corresponding peritumoural tissues (n.16); histologically‐normal liver (n.4) as controls. Fas, FasL and IL‐1β mRNA were quantified using reverse transcriptase‐polymerase chain reaction. The apoptotic index was evaluated by TUNEL analysis. Our data showed a progressive Fas / FasL increase from CH to cirrhosis followed by a decline from the latter to HCC. In histological sections apoptosis was detected in HCC. A significant difference emerged between HCV and HBV‐related disease for IL‐1β expression only in CH. A significant positive correlation between IL‐1β and FasL in HCV‐related disease (P = 0.014) and an inverse correlation between IL‐1β and Fas in HBV‐related disease (P = 0.021) were observed. The different pattern of IL‐1β, Fas and FasL expression found in HCV‐ and HBV‐mediated liver disease, points to a different modulation of immune response B and C virus induced, while the decline in Fas / FasL expression in HCC may be related to defence mechanisms adopted by HCC cells against the immune system.Keywords
This publication has 38 references indexed in Scilit:
- Cellular Immune Responses against Hepatitis C VirusClinical Infectious Diseases, 2005
- Kupffer cell–derived Fas Ligand plays a role in liver injury and hepatocyte deathJournal of Gastrointestinal Surgery, 2004
- Exploring the Biological Basis of Hepatitis B E Antigen in Hepatitis B Virus InfectionHepatology, 2003
- Apoptosis in liver diseaseEuropean Journal of Gastroenterology & Hepatology, 2001
- Expression of Fas and anti-Fas-mediated apoptosis in human hepatocellular carcinoma cell linesJournal of Hepatology, 1996
- Fas antigen expression in liver tissues of patients with chronic hepatitis BJournal of Hepatology, 1996
- Human Fas ligand: gene structure, chromosomal location and species specificityInternational Immunology, 1994
- Fas and Perforin Pathways as Major Mechanisms of T Cell-Mediated CytotoxicityScience, 1994
- Immunohistochemical detection of Fas antigen in liver tissue of patients with chronic hepatitis CHepatology, 1994
- Purification and characterization of the Fas-ligand that induces apoptosis.Journal of Experimental Medicine, 1994